From Department of Medicine, Division of General Internal Medicine, Weill Cornell Medicine, New York, NY (LCP, MR, MMS, LMK); Department of Medicine, Division of Hematology and Oncology, Weill Cornell Medicine, New York, NY (DMN).
J Am Board Fam Med. 2022 Jul-Aug;35(4):827-832. doi: 10.3122/jabfm.2022.04.220007.
During cancer treatments, patients often defer primary care and comorbidity management, which may not be optimal for overall health when patients transition into survivorship. We sought to quantify primary care utilization among cancer survivors who are ≥2 years post cancer treatments.
951 cancer survivors were included in this national, prospective cohort study using the Regional Geographic and Racial Differences in Stroke (REGARDS) data.
Nearly all (91.6%) cancer survivors had at least 1 annual PCP visit and most (54.6%) had a PCP as their dominant provider.
These findings underscore the urgent need for smooth handoffs from oncology back to primary care.
在癌症治疗期间，患者往往会推迟初级保健和合并症管理，而当他们进入生存阶段时，这可能对整体健康状况不利。我们旨在量化癌症治疗后 ≥2 年的癌症幸存者的初级保健利用情况。
本项全国性前瞻性队列研究使用区域地理和中风种族差异（REGARDS）数据，共纳入 951 名癌症幸存者。
几乎所有（91.6%）的癌症幸存者每年至少有 1 次接受 PCP 就诊，大多数（54.6%）患者将 PCP 作为其主要提供者。
这些发现强调了从肿瘤学顺利过渡到初级保健的迫切需要。
